In France, the use of the antimalarial drug hydroxychloroquine for the treatment of patients with COVID-19 was banned. On Wednesday, May 27, according to the government publication Journal-officiel. " In particular, in this provision it was said that hydroxychloroquine can be prescribed in medical institutions under the responsibility of a doctor to patients with COVID-19. On Tuesday, the French Medicines Agency announced its intention to suspend, for the sake of precaution, trials of hydroxychloroquine as a medicine for COVID-19. However, the agency noted that " According to authorities, a total of 16 such clinical trials are currently underway in France. The French High Health Council previously recommended that hydroxychloroquine be discontinued in the treatment of COVID-19 outside of clinical trials. This recommendation was announced after the French Minister of Health Olivier Veran asked to review the rules for prescribing this drug in connection with the publication of a study in the medical journal The Lancet, which talked about the inefficiency and even danger of death in some cases when using chloroquine in the treatment of patients with coronavirus. Recall, on May 25, WHO Director-General Tedros Adan Gebreyesus said that the organization temporarily suspended tests of hydroxychloroquine and chloroquine in the treatment of COVID-19. Recall, US President Trump admitted that he regularly took hydroxychloroquine for the prevention of coronavirus. News from Telegram. Subscribe to our channel https: // t. me / korrespondentnet Author: 1.